Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults

Clinical trial NCT06972212 · COMPLETED

Trial details

NCT number: NCT06972212
Sponsor: Latigo Biotherapeutics
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pain Detection Pain Threshold

Start date: 2025-06-04
Primary completion: 2025-06-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.